Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms

Chest

Volumn 122, Issue 6, 2002, Pages 2015-2020

  Sarrell, E Michael ^a,b   Tal, Guy ^a,b   Witzling, Michaela ^a,b   Someck, Eli ^a,b   Houri, Sion ^a,b   Cohen, Herman A ^a,b   Mandelberg, Avigdor ^a,b  

^a WOLFSON MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Ambulatory; Hypertonic saline solution; Respiratory syncytial virus; Terbutaline; Viral bronchiolitis; 2 agonist

Indexed keywords

SODIUM CHLORIDE; TERBUTALINE;

ARTICLE; BRONCHIOLITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INFANT; INFANT DISEASE; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; NEBULIZATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0036923821     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.6.2015     Document Type: Article

References (38)

1. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001; 344:1917-1928
2. Glezen WT, Greenberg SB, Atmar RL, et al. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 2000; 283:499-505
3. The prospects for immunizing against respiratory syncytial virus. In: Institute of Medicine Committee on issues and priorities for new vaccine development. New Vaccine Development: Establishing Priorities. Vol 2. Diseases of Importance in Developing Countries. Washington, DC: National Academy Press, 1986; 299-308
4. Langley JM, Wang EE, Law BJ, et al. Economic evaluation of respiratory syncytial virus infection in Canadian children: A Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. J Pediatr 1997; 131:113-117
5. Darville T, Yamauchi T. Respiratory syncytial virus. Pediatr Rev 1998; 19:55-61
6. Smith DW, Frankel LR, Mathers LH, et al. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N Engl J Med 1991; 325:24-29
7. Meert KL, Sarnik AP, Gelmini MJ, et al. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: A prospective double-blind, randomized trial. Crit Care Med 1994; 22:566-572
8. Moler FW, Steinhart CM, Ohmit SE, et al. Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. J Pediatr 1996; 128:442-448
9. Guerguerian A-M, Gauthier M, Lebel MH, et al. Ribavirin in ventilated respiratory syncytial virus bronchiolitis: A randomized, placebo-controlled trial. Am J Respir Crit Care Med 1999; 160:829-834
10. Wheeler JG, Wofford J, Turner RB. Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infection. Pediatr Infect Dis J 1993; 12:209-213
11. Van Woensel JB, Wolfs TF, van Aalderen WM, et al. Randomized double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. Thorax 1997; 52:634-637
12. Cade A, Brownlee KG, Conway SP, et al. Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis. Arch Dis Child 2000; 82:126-130
13. Menon K, Sutcliffe T, Klassen TP. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J Pediatr 1995; 126:1004-1007
14. Dobson JV, Stephens-Groff SM, McMahon SR, et al. The use of albuterol in hospitalized infants with bronchiolitis. Pediatrics 1998; 101:361-368
15. Barr FE, Patel NR, Newth CJL. The pharmacologic mechanism by which inhaled epinephrine reduces airway obstruction in respiratory syncytial virus associated bronchiolitis. J Pediatr 2000; 136:699-700
16. Bertrand P, Aranibar H, Castro E, et al. Efficacy of nebulized epinephrine vs salbutamol in hospitalized infants with bronchiolitis. Pediatr Pulmonol 2001; 31:284-288
17. 2-agonists in bronchiolitis: A reappraisal and meta-analysis. Pediatrics 1997; 100:233-239
18. Welliver JR, Welliver RC. Bronchiolitis. Pediatr Rev 1993; 14:134-139
19. Nasr SZ, Strouse PJ, Soskoline E, et al. Efficacy of recombinant human deoxyribonuclease I in the hospital management of respiratory syncytial virus bronchiolitis. Chest 2001; 120:203-208
20. Wark PAB, McDonald V. Nebulised hypertonic saline for cystic fibrosis (Cochrane Review). In: The Cochrane Library. Vol 2. Oxford, UK: Update Software, 2001
21. Eng PA, Morton J, Douglass JA, et al. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatr Pulmonol 1996; 21:77-83
22. Riedler J, Reade T, Button B, et al. Inhaled hypertonic saline increases sputum expectoration in cystic fibrosis. J Paediatr Child Health 1996; 32:48-50
23. Robinson M, Regnis JA, Bailey DL, et al. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Am J Respir Crit Care Med 1996; 153:1503-1509
24. Robinson M, Hemming AL, Regnis JA, et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax 1997; 52:900-903
25. Robinson M, Daviskas E, Eberl S, et al. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: A pilot study. Eur Respir J 1999; 14:678-685
26. King M, Dasgupta B, Tomkiewicz RP, et al. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I. Am J Respir Crit Care Med 1997; 156:173-177
27. Dasgupta B, Tomkiewicz RP, Boyd WA, et al. Combined effect of hypertonic saline and rhDNase on cystic fibrosis sputum in vitro. Pediatr Pulmonol 1995; 20(Suppl 12):A201-A236
28. Tomooka LT, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation. Laryngoscope 2000; 110:1189-1193
29. Wang EE, Milner RA, Navas L, et al. Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections. Am Rev Respir Dis 1992; 145:106-109
30. Nasr SZ, Kuhns LR, Brown RW, et al. Use of computerized tomography and chest X-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: A preliminary study. Pediatr Pulmonol 2001; 31:377-382
31. Angle N, Hoyt DB, Coimbra R, et al. Hypertonic saline resuscitation diminishes lung injury by suppressing neutrophil activation after hemorrhagic shock. Shock 1998; 9:164-170
32. Angle N, Hoyt DB, Cabello-Passini R, et al. Hypertonic saline resuscitation reduces neutrophil margination by suppressing neutrophil L selectin expression. J Trauma 1998; 45:7-12; discussion 12-13
33. Murao Y, Hoyt DB, Loomis W, et al. Does the timing of hypertonic saline resuscitation affect its potential to prevent lung damage? Shock 2000; 14:18-23
34. Spencer H. Pathology of the Lung. Oxford, UK: Pergamon Press, 1985; 131-165
35. Walsh EE, Falsey AR, Hennessey PA. Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am J Respir Crit Care Med 1999; 160:791-795
36. Wald T, Miller B, Shult P, et al. Can respiratory syncytial virus and influenza A be distinguished clinically in institutionalized older persons? J Am Geriatr Soc 1995; 43:170-174
37. Babcook JC, Norman GR, Coblentz CL. Effect of clinical history on the interpretation of chest radiographs in childhood bronchiolitis. Invest Radiol 1993; 28:214-217
38. Boek WM, Keles, Graamans K, et al. Physiologic and hypertonic saline solutions impair ciliary activity in vitro. Laryngoscope 1999; 109:396-399